Mixed Results in June; Tech Stocks Continue to Outperform

Stocks Climb Higher; Seasonal COVID-19 Surge Poses Risk

November 30, 2020

The Dow, NASDAQ and S&P 500 are now all in positive territory for the year.

The difficulties facing the economy and the markets shouldn’t be understated, but through November the promise of normal was seemingly a powerful counter.

As COVID-19 cases continued to reach new highs, investors were bolstered by positive developments, the greatest of which was encouraging news about three COVID-19 vaccines that were shown to be highly effective through trials. Corporate earnings for the third quarter were also stronger than expected, providing a greater than expected boost, and the likelihood of a split federal government may have eased fears about broad changes to taxation.

As a result – in addition to the Dow’s new 30,000 high – the S&P 500 posted its strongest month since April and the Russell 2000, which has tracked smaller companies’ stocks since 1984, saw its largest increase on record.

“While the vaccine will likely not be widely available to the general public until the first quarter of 2021, at the earliest, the positive efficacy results through the vaccine trials led some of the most virus-sensitive companies’ stocks to outperform,” Raymond James Chief Investment Officer Larry Adam said.

Looking more broadly at the economy, indicators continue to show signs of improvement, but at a more moderate pace compared to summer – surging infection rates through the holiday season pose a downside risk to the economy into early 2021.

“A number of fiscal policy initiatives are (also) set to expire at year-end and the prospects for further support from Congress remain uncertain,” Chief Economist Scott Brown said. “However, the economy is expected to pick up significantly as vaccines are distributed next year.”

 

  12/31/19 Close  

  11/30/20 Close  

Change
  Year to Date  

% Gain/Loss
  Year to Date  

DJIA

28,538.44

29,638.64

+1,100.20

+3.86 %

NASDAQ

8,972.61

12,198.74

+3,226.13

+35.96 %

S&P 500

3,230.78

3,621.63

+390.85

+12.10 %

MSCI EAFE

2,036.96

2,053.83

+16.87

+0.83 %

Russell 2000

1,668.47

1,819.82

+151.35

+9.07 %

Bloomberg Barclays
U.S. Aggregate Bond Index

2,225.00

2,387.01

+162.01

+7.28 %

Performance reflects price returns as of market close on Nov. 30, 2020. MSCI EAFE and Bloomberg Barclays Aggregate Bond values represent Nov. 27 closing prices.

Georgia on everybody’s mind

While there was hope that the election would calm political tempers and make it easier for the House, Senate and administration to reach a fiscal stimulus compromise, the continuing contests to decide the leadership of the Senate may have thrown those wishes to the wind.

“The back and forth on partisan positions for the next fiscal bill continues, and we view the politics of the Georgia runoff races as playing a significant role,” Washington Policy Analyst Ed Mills said. “We expect positions to become clearer once Congress returns from the Thanksgiving recess.”

Comments from Ron Klain, presumptive President-elect Joe Biden’s chief of staff, suggest Biden is supporting a compromise package during the lame duck period, possibly in line with the $1.5 trillion package proposed by the House’s bipartisan Problem Solvers Caucus, but significant hurdles remain.

It’s not just equities

Hopes for the eventual return to normalcy pushed credit spreads, both high yield and investment grade, to new COVID-19-era lows and pushed energy prices to the highest level since March. We also saw the biggest bond yield swings since the start of the pandemic.

Demand for corporate debt continues to be strong, and both municipal and corporate bonds outperformed Treasuries through the month.

Oil prices, however, “will likely remain choppy over the next three to four months,” Energy Analyst Pavel Molchanov said. “Although current lockdown restrictions across Europe and a dozen U.S. states are milder than the original ones in March and April, the amount of population affected is so large that impact on transportation and traffic is still unavoidable.”

The bottom line

The markets are showing a sense of optimism for the year ahead, as evidenced by some of the most sensitive sectors’ outcomes through November.

“We saw Energy stocks trading up 39%, Financials up 20% and Industrials up 18% in just 17 days,” said Joey Madere, senior portfolio strategist, Equity Portfolio & Technical Strategy. “While we are positive over the next six to 12 months, we would not be surprised for the road to be bumpy in the coming weeks and months.”

Your advisor will continue to share any new developments that affect your financial plan. In the meantime, please reach out to them with any questions.

Investing involves risk, and investors may incur a profit or a loss. All expressions of opinion reflect the judgment of the authors and are subject to change. There is no assurance the trends mentioned will continue or that the forecasts discussed will be realized. Past performance may not be indicative of future results. Economic and market conditions are subject to change. The Dow Jones Industrial Average is an unmanaged index of 30 widely held stocks. The NASDAQ Composite Index is an unmanaged index of all common stocks listed on the NASDAQ National Stock Market. The S&P 500 is an unmanaged index of 500 widely held stocks. The MSCI EAFE (Europe, Australia, Far East) index is an unmanaged index that is generally considered representative of the international stock market. The Russell 2000 is an unmanaged index of small cap securities. The Bloomberg Barclays US Aggregate Bond Index is a broad-based flagship benchmark that measures the investment grade, U.S. dollar-denominated, fixed-rate taxable bond market. An investment cannot be made in these indexes. Investing in commodities is generally considered speculative because of the significant potential for investment loss. Their markets are likely to be volatile and there may be sharp price fluctuations even during periods when prices overall are rising. Raymond James does not provide tax services. Please discuss these matters with the appropriate professional.